The FDA removes a long-standing warning from hormone-based menopause drugs

Hormone-based drugs used to treat hot flashes and other menopause symptoms will no longer carry a bold warning label about stroke, heart attack, dementia and other serious risks, the Food and Drug Administration announced Monday.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup